same general area and much besides. However, the present volume does serve a useful purpose in focussing in more detail on malignant disease, and also provides one or two introductory chapters on HLA background studies. It is one of the disappointments and paradoxes of HLA and disease associations that few convincing associations between HLA and human malignancies have been demonstrated; this in spite of the important role of mouse MHC in determining resistance and susceptibility to both experimental and naturally occurring leukaemias. Part of the problem with human malignancy must of course be in the genetic heterogeneity of human populations. Another "procedural" problem is the necessity for prospective surveys. If an HLA specificity confers, directly or indirectly, resistance to a particular malignancy, one would expect a reduced frequency of the antigen amongst patients at the time of presentation with their disease.
Conversely, as patients began to die the "resistance antigen" might be expected to rise in frequency amongst the survivors. This sort of study is much more difficult to set up and takes much longer than a survey of a mixed group of patients at various stages of their disease, and the effects of a resistance gene would be obscured. There is now good evidence that this occurs in Hodgkin's disease, acute lymphoblastic leukaemia and acute myelogeneous leukaemia. This valuable series continues on its way (at ever-increasing prices) and now covers many of the major tumour sites. The volume on testis tumours is well up to the high standard of recent volumes in the series. Dr. Mostofi was co-author of the 1973 A.F.I.P. volume 'Tumors of the Male Genital System", and the present volume adopts broadly the same classification. Pathologists accustomed to the British Institute of Urology's classification of testicular germ-cell tumours may be disconcerted to find an apparently different system adopted here. The differences are not, in fact, very great. Most tumours that British pathologists -would class as Malignant Teratoma Intermediate, or Undifferentiated, are grouped here as Embryonal Carcinoma, with or without Teratoma. It has to be admitted that many tumours labelled as malignant teratoma in the British system consist entirely of malignant epithelial
